C
CNTA
Centessa Pharmaceuticals Plc
39.44
-0.13-0.33%Opening12:55 04/14 EDT
OPEN/PREV CLOSE39.58/39.57
TODAY RANGE39.38-39.60
VOL1.21M
MARKET CAP6.10B
52 WEEK RANGE10.95-40.26
AVG VOL (3M)2.50M
% TURNOVER0.78%
TURNOVER--
P/E (TTM)-27.0972
% RANGE0.56%
EPS(TTM)-1.4555
P/E(FORWARD)-23.7590
P/B17.69
BVPS2.244
DIVIDEND--
P/S323.05
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.66B
SHARES OUTSTANDING154.66M
NEXT EARNINGS05/12-05/18
FREE FLOAT143.47M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Centessa downgraded to Hold from Buy at Truist
Seeking Alpha·5d ago
Centessa is the top performing foreign healthcare stock YTD
Benzinga·04/03 14:35
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy
Seeking Alpha·04/02 16:49
Biotech Is Holding Steady In 2026
Benzinga·04/02 15:34
This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Dow Jones·04/02 13:56
Centessa Pharmaceuticals Cut to Neutral From Buy by Guggenheim
Benzinga·04/02 13:47
Guggenheim Downgrades Centessa Pharmaceuticals to Neutral
Dow Jones·04/01 20:38
Centessa Pharmaceuticals Cut to Market Perform From Outperform by Leerink Partners
TipRanks·04/01 16:00
Centessa downgraded to Neutral from Buy at Guggenheim
Benzinga·04/01 14:43
Centessa Pharmaceuticals Agrees To Eli Lilly Acquisition At 40% Premium
TipRanks·04/01 13:51
Disney upgraded, Nike downgraded: Wall Street’s top analyst calls
TipRanks·04/01 11:52
Centessa downgraded to Market Perform from Outperform at LifeSci Capital
NASDAQ·04/01 10:58
Centessa Pharmaceuticals Reaches Analyst Target Price
Same Industry
Name/Symbol
Change%
Price